Houlihan Lokey, Inc.

  • Market Cap: Small Cap
  • Industry: Capital Markets
  • ISIN: US4415931009
USD
179.36
2.64 (1.49%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Houlihan Lokey, Inc. stock-summary
stock-summary
Houlihan Lokey, Inc.
Capital Markets
Houlihan Lokey, Inc. is a global independent investment bank that focuses on mergers and acquisitions (M&A), capital markets, financial restructuring, valuation, and strategic consulting. The Company operates through three segments: Corporate Finance, Financial Restructuring and Financial Advisory Services. The Company provides financial professionals with an integrated platform that enables them to deliver advice to its clients. The Corporate Finance activities include two categories: M&A and capital markets advisory. The Financial Advisory Services segment includes financial opinions, and a range of valuation and financial consulting services in the United States. It also provides strategic consulting services to clients. The Financial Restructuring segment provides advice to debtors and creditors.
Company Coordinates stock-summary
Company Details
10250 Constellation Blvd Fl 5 , LOS ANGELES CA : 90067-6205
stock-summary
Tel: 1 310 5538871
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 112 Schemes (55.31%)

Foreign Institutions

Held by 169 Foreign Institutions (12.48%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Scott Adelson
Co-President and Global Co-Head of Corporate Finance, Director
Mr. David Preiser
Co-President, Director
Mr. Scott Beiser
Chief Executive Officer, Director
Mr. Irwin Gold
Executive Chairman of the Board
Ms. Ekpedeme Bassey
Independent Director
Dr. Jacqueline Kosecoff
Independent Director
Mr. Robert Schriesheim
Independent Director
Mr. Cyrus Walker
Independent Director
Mr. Paul Zuber
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
606 Million
(Quarterly Results - Jun 2025)
Net Profit:
98 Million
stock-summary
Industry

Capital Markets

stock-summary
Market cap

USD 13,959 Million (Small Cap)

stock-summary
P/E

30.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

1.16%

stock-summary
Debt Equity

-999,999.00

stock-summary
Return on Equity

20.41%

stock-summary
Price to Book

6.41